Rapid onset of protection against infectious bovine rhinotracheitis with a modified-live virus multivalent vaccine.
This study provides evidence that subcutaneous vaccination of cattle with a commercially available modified-live virus combination vaccine can help reduce clinical signs associated with infectious bovine rhinotracheitis infections in feedlot animals vaccinated at the time of arrival. Calves vaccinated 72 or 96 hours before challenge had reduced clinical signs, lower body temperatures, lower virus titers, and 39% to 76% greater weight gains compared with nonvaccinated controls.
Fairbanks
Kris Fogarty
KF
Rural Technologies, Inc, Brookings, SD 57006, USA.
Campbell
Joe
J
Chase
Christopher C L
CC
D000281:Administration, Intranasal; D000818:Animals; D000831:Animals, Newborn; D000914:Antibodies, Viral / Q000032:analysis; D001831:Body Temperature; D002417:Cattle; D001908:Diarrhea Viruses, Bovine Viral / Q000276:immunology; D007242:Herpesvirus 1, Bovine / Q000276:immunology*; D007241:Infectious Bovine Rhinotracheitis / Q000517:prevention & control*; D010224:Parainfluenza Virus 3, Human / Q000276:immunology; D018108:Respirovirus / Q000276:immunology; D014611:Vaccination / Q000662:veterinary; D014613:Vaccines, Attenuated; D014765:Viral Vaccines / Q000008:administration & dosage
D000914:Antibodies, Viral; D014613:Vaccines, Attenuated; D014765:Viral Vaccines